Abstract
Anthelmintic resistance in the United States has recently gained the attention of the veterinary and livestock communities. The rapid rise in resistance to 2 new drug classes shortly after approval outside the United States calls for new strategies and recommendations for maintaining an effective anthelmintic program even as new drugs become available. The development of resistance is product-dependent, with observable differences between classes. Methods used to test anthelmintic efficacy allow the veterinary practitioner to make informed treatment decisions; however, the results should be interpreted carefully due to the limitations for the fecal egg count procedure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Association of Bovine Practitioners Conference Proceedings
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
